Current knowledge on the development regulation of cell surface carbohydrates and lectins in mammalian embryos is summarized. Much of this data comes from observations on mouse embryos but information on the human embryo is included where it is available. Over the last few years, numerous studies have indicated that carbohydrates play a critical role in the cell-cell interactions of the pre-and peri-implantation embryo. Functional tests suggest a role for terminal fucosylated Galβ1-3/4GlcNAc structures in the early steps of implantation. We also now have clear evidence for the expression of lectins in the trophectoderm just prior to implantation. Mouse mutants have been generated which lack particular enzymes involved in glycosylation or particular lectins, but so far they have not been informative about the role of glycoconjugates or lectins in the very early embryo.
Introduction
Our understanding of the functional importance of carbohydrate modification of proteins and lipids has grown dramatically in the last decade. This, together with significant advances in the methodology for studying oligo-and polysaccharide chain structures, has brought carbohydrate biology to centre-stage in the study of cell interactions and behaviour.
Firstly, it has become clear that cell surface carbohydrates carry specific information involved in cell recognition. This had been predicted from the large number of different bonds possible between the common monosaccharide units and their sulphated and acetylated derivatives (Kobata, 1993) . The formation of links between the monosaccharides is catalysed by hundreds of bond-specific glycosyltransferases. However, until the last decade, the evidence for specific recognition functions for carbohydrates was limited. It was mainly restricted to certain species such as sponges, although some information was also available on mammalian cells during development (Ashwell and Harford, 1982; Bird and Kimber, 1984; Fenderson et al., 1984; Florman and Wassarman, 1985; Misevic et al., 1987) . However, it is now clear that carbohydrates can interact with other carbohydrates, as well as with certain proteins called lectins (Eggens et al., 1989; Hakomori, 1992) . The affinity of interaction as measured in vitro between individual molecules is often low compared to protein-protein interactions, but the strength of carbohydrate-carbohydrate or carbohydrate-lectin binding may be increased in vivo by multiple molecular interactions.
In the 1980s, a number of publications described several families of lectins able to interpret the specific information carried by carbohydrate structures in animal cells. These animal lectins fell into two main groups: C-type (calcium dependent) and S-type (calcium-independent) (Drickamer and Taylor, 1993) . In the context of this review, the most relevant group of C-type lectins is the selectin family consisting of three members called E, P and L. The selectins have been found to be involved in lymphocyte homing to high endothelial venules and in the initial processes of attachment of leukocytes to endothelial cells at sites of inflammation (Lasky, 1995; Tedder et al., 1995) . Neutrophils are first slowed in the blood vesssels of inflamed tissue by undergoing a process of rolling along the endothelial wall. This slowing of motion and primary contact allows other firmer, higher affinity, cell-cell adhesion mechanisms to come into play, including β 2 integrins and intracellular adhesion (ICAM) family molecules. E-selectin and P-selectin on endothelia and platelets interact with terminal oligosaccharide structures on glycolipids and/or glycoproteins of neutrophils, while L-selectin on lymphocytes interacts with endothelial carbohydrates. Calcium dependent interaction occurs via a single N-terminal carbohydrate recognition domain (CRD) of the type I transmembrane molecules. Lewis (Le x )-related terminal sugar groups (see Table I ), particularly sialylLe x for E-and P-selectins and sulphated Le x for P-and Lselectins, were suggested as the ligands most likely to be involved. However, it now seems likely that complex higher order structures containing more than one oligosaccharide chain play a role (Varki, 1994; Crottet et al., 1996) . Selectins participate in the initial step of a cascade of adhesive events which may have similarities to the sequence of adhesion steps occuring at implantation (Kimber et al., 1994b ; see section on implantation).
S-type lectins, now renamed galectins, are a group of 10 known soluble lectins that share structural similarity and exhibit specificity for β-galactosides (Barondes, 1984; Barondes et al., 1994a,b; Leffler, 1997) . The galectin CRD consists of~135 
amino acids. Some galectins have only one CRD but are dimeric (e.g. galectin 1), others form oligomers (e.g. galectin 3) and a third group contains two CRD in the same polypeptide (Leffler, 1997) . These molecules can be found either inside the cells, or in association with the cell membrane or the extracellular matrix to which they are transported by a nonclassical secretion pathway (Cooper and Barondes, 1990; Lindstedt et al., 1993; Sato et al., 1993) . Galectins are expressed in a large variety of cell types and developmental stages starting from the preimplantation stages of mouse embryogenesis (Poirier et al., 1992; Poirier and Robertson, 1993; Colnot et al., 1996 Colnot et al., , 1997 .
In this review, we will focus on current knowledge about cell surface carbohydrates and their binding molecules in preand peri-implantation mammalian development. We will select examples where we have recently obtained clues about the interactions and possible function of some of these molecules at the cell surface. The limited availability of human embryos together with ethical considerations means that much of this information comes from animal models, predominantly the mouse. However, evidence is rapidly accumulating for the universality of mechanisms regulating differentiation and cell behaviour in development across the animal kingdom (see for example the Hox genes, McGinnis and Krumlauf, 1992) . We must be cautious about extrapolation between species at the level of the precise molecule or epitope which performs a specific function. However, we can be reasonably confident that the general mechanisms governing cell behaviour will be conserved.
Carbohydrate structures
In animal cells, saccharide chains may be attached both to lipids and proteins and can vary from a single sugar to long chains of Ͼ30 residues which may be branched (Fukuda, 1994) . There are two major linkages by which carbohydrate chains can be attached to proteins: either N-linked through an asparagine residue, or O-linked through a threonine or serine. A given glycoprotein may contain only N-linked, only O-linked, or both types of oligosaccharide chains (Goochee et al., 1991) . Oligosaccharides may also be linked via O-glycosidic bonds to ceramide in glycolipids (Welply, 1989) . Although the core structures differ, there may be similarities in the extensions and terminal sequences of N-, O-, and lipidlinked sugar chains (for review see Igarashi et al., 1989 
Carbohydrates and their ligands during early development

Fertilization
In mammalian reproductive biology, the role of sugars was first identified in the process of fertilization (for reviews see Wassarman, 1988 see Wassarman, , 1995 Wasserman et al., 1996; Snell and White, 1996) . In all mammals examined, including humans, the capacitated spermatozoon binds first to a sperm receptor glycoprotein (ZP3) on the zona pellucida. The specific oligosaccharide structures on ZP3 are characteristic of each species (Wassarman, 1988) . ZP3 is modified after fertilization so that additional spermatozoa can no longer interact with it (Bleil and Wassarman, 1980) . Sperm interaction occurs with ZP3 oligosaccharides O-linked to serine or threonine (Florman and Wassarman, 1985) . A specific subset of ZP3 oligosaccharides has been shown to have sperm receptor activity and these are associated with the C-terminal one third of the peptide (Wassarman, 1990; Rosiere and Wassarman, 1992) . Terminal Gal and GlcNAc residues have both been suggested to be important in mouse ZP3 binding to spermatozoa, though recent data may tip the balance in favour of terminal Gal (Litscher et al., 1995) . Branched bi-or tetra-antennary oligosaccharide constructs containing terminal Gal inhibit binding between mouse spermatozoa and unfertilized oocytes at concentrations of 4-10 µM in vitro (Litscher et al., 1995) . Simple mono-or di-saccharides or unbranched chains carrying terminal Gal were ineffective. Recently, the murine ZP3 gene has been mutated using homologous recombination in embryonic stem (ES) cells. Homozygous null oocytes appear to grow normally but lack a zona pellucida. Normal interaction with follicle cells in the ovary is altered, the number of ovulated ovocytes is reduced and the fertilized embryos die before the 2-cell stage, possibly due to the adhesion of zona-free embryos to the oviduct wall (Liu et al., 1996a; Rankin et al., 1996) .
Various candidates for the receptor on spermatozoa have been suggested (for review see Snell and White, 1996) , including β1-4-galactosyltransferase, a cell surface enzyme on the murine sperm head which recognizes terminal GlcNAc residues on ZP3 (Miller et al., 1992; Youakim et al., 1994) . A lectin-like protein on the murine sperm membrane, sp56, which recognizes terminal Gal residues on ZP3 carbohydrate chains, is another potential candidate (Bookbinder et al., 1995) , as is the 95 kDa putative transmembrane tyrosine kinase identified by Leyton and Saling (1989) . Primakoff's group has also identified PH-20, a lipid-linked sperm and acrosome membrane protein with hyaluronidase activity which promotes cumulus penetration and could be involved in zona binding (Primakoff et al., 1985; Lin et al., 1994) .
Very little is known about the carbohydrate structures involved in binding of human ZP3 to spermatozoa. Sugar inhibition studies have implicated mannosylated structures, but high concentration of mannose were required to prevent sperm binding . However, D-mannose binding sites have been localized on the human sperm surface (Tesarik et al., 1991) . Fucoidan, a polysaccharide rich in fucose inhibits human sperm-zona binding (Oehninger et al., 1991) and fucose, particularly in the form of the Le b antigen (see Table  I ) is present in human zonae pellucidae independent of blood group status (Lucas et al., 1994) . Moreover, a monoclonal antibody (MAb) to Le b (Fuc α 1-2 Gal β 1-3 [Fuc α1-4] GlcNAc) inhibited sperm-zona binding, suggesting Le b either forms part of the sperm receptor, or is in close vicinity to it. Fucosylated Gal-GlcNAc epitopes additionally substituted with sialic acid or sulphate groups (e.g. sialyl-Le x ) are ligands for selectins. Indeed, a selectin-like interaction for human sperm-zona binding has also been suggested .
Further research is needed to clarify the identity of ZP3 carbohydrate ligand(s) on mouse and human spermatozoa.
Preimplantation development
As the dividing embryo moves through the Fallopian tube (oviduct) and into the uterus, it undergoes a process of increased cell-cell contact and polarization of outer blastomeres, called 'compaction'. Also at this time, trophectoderm differentiates and the embryo cavitates forming a blastocyst. A well ordered sequence of cell surface modifications occurs as the embryo proceeds from compaction to a fully cavitated blastocyst with mature trophectodermal epithelium (Kimber, 1990; Fleming et al., 1994) , which includes changes in the carbohydrates expressed on the cell surface. Much of the information on carbohydrate changes accumulated during the 1980s has already been reviewed (Kimber, 1990; Fenderson et al., 1990) .
Key landmarks in the maturation of the cell surface of the murine embryo are the appearances of new carbohydrate antigens. For instance SSEA-1 (Le x ) and sialyl-Le x appear at the 8-cell stage prior to compaction (Solter and Knowles, 1978; Kimber et al., 1993) . The effects of neoglycoproteins and oligosaccharides on compacting murine embryos in vitro suggested that the Le x antigen may be involved in the stabiliza-909 tion of compaction (Bird and Kimber, 1984; Fenderson et al., 1984) , an event driven by E-cadherin-mediated cell-cell adhesion (Hyafil et al., 1980; Collins and Fleming, 1995) .
Changes in the carbohydrate profile have yet to be described for the preimplantation human embryo but differentiation of human embryonal carcinoma (EC) cells shows a generalized transition from globo-series (GalNAcβ1-3 Galα1-4 Galβ1-4Glc Cer) to lacto-series (Galβ1-4GlcNAcβ)-based chains (Fenderson et al., 1987) . On the mouse embryo, lacto-series chains, such the I antigen, are present from the 1-cell stage (reviewed in Kimber, 1990 ). This highlights the need for caution when extrapolating data between species. However, differences may also reflect the evident variation between different EC cell lines. The embryonic stages to which these lines correspond to cannot be precisely identified.
Terminal sialylation of glycoconjugates modulates cell behaviour not only through specific recognition events, but also through the influence of its negative charge. Sialylated structures, such as α2-3 sialylated gangliosides and globosides are expressed in cleaving mouse embryos (Kannagi et al., 1983; Pennington et al., 1985; Kimber, 1990 ), but NeuNAc α2-6Galβ1-and NeuNAcα2-Galα1-3GalNAc-cannot be detected on the preimplantation embryo (Kimber et al., 1993) . We also identified sialyl-Le a on the embryonic cell surface from the morula stage. Furthermore, α2-8 linked polysialic acids were detected on mouse embryos from the 4-8-cell stage (Kimber et al., 1993; . These unusual α2-8 linked polysialic acid structures (Rougon et al., 1986) are characteristic of N-CAM (neural cell adhesion molecule). They are particularly abundant on the embryonic form of this immunoglobulin super-family cell-adhesion molecule (Rothbard et al., 1982) . N-CAM itself was detected in the unfertilized egg and weakly on early cleaving mouse embryos, but the intensity of staining increased at the 8-cell to morula stage (Kimber et al., 1994a) . Thus oocytes and early cleaving embryos may express N-CAM lacking polysialic acid. Since the sialic acid moieties of N-CAM decrease its binding affinity (Rutishauser et al., 1985 (Rutishauser et al., , 1988 , this may indicate weaker N-CAM mediated cell adhesion as embryos progress from cleavage into compaction when other cell adhesion systems take over (Fleming et al., 1994) . We also detected N-CAM on human oocytes and morulae (Campbell et al., 1995a) , but limited material has precluded investigation of α2-8 polysialylation. N-CAM has been suggested to mediate its effects on neurite outgrowth less by its weak adhesive properties than via activation of intracellular signalling pathways (Doherty et al., 1994) . Its major function in regulating neurite outgrowth may be facilitation of the Gprotein dependent activation of L-and N-type calcium channels (Doherty et al., 1991) . Calcium levels are also crucial to early developmental events including E-cadherin-mediated cell-cell adhesion at compaction (Hyafil et al., 1981; Ducibella et al., 1975) . Thus a role of N-CAM in regulating calcium channels in preimplantation mammalian embryos is possible. Alternatively, N-CAM is also able to bind heparan sulphate proteoglycan (HSPG) (Cole and Glaser, 1986; Kallapur and Akeson, 1992) . One form of HSPG, perlecan, is up-regulated on hatching blastocysts and appears to be involved in blastocyst attachment see below) . CD44 has also been identified on preimplantation human embryos (Campbell et al., 1995b) . The precise isoform(s) of CD44 expressed by human pre-and peri-implantation embryos is not known but one of them, CD44-H, is a hyaluronate receptor (Knudson and Knudson, 1993) . However, hyaluronate is cleared from the ECM of mouse antimesometrial decidual cells, suggesting that the receptor is not involved in trophoblast invasion (Brown and Papaioannou, 1992) .
In conclusion, the large number of negatively charged sialic acid residues on the surface of preimplantation embryos may function in various non-exclusive ways including the regulation of cation interaction with different membrane components and the mobility or localization of other glycoconjugates (Sharom and Grant, 1978; Cheresh et al., 1987; Rodriguez-Boulan and Zurzolo, 1993) . Additionally, gangliosides have been implicated in interactions with extracellular matrix molecules (Bremer et al., 1986; Cheresh et al., 1986; Zheng et al., 1993) and sialomucins have been postulated to be regulators of cell interaction and proliferation (Carraway et al., 1992; Aplin et al., 1994) .
Implantation
From rodent studies, it has been learnt that in order for implantation to occur, the trophectoderm must first become activated to form trophoblast. The blastocyst and luminal epithelium (LE) must then come into close proximity; a process known as apposition. Implantation occurs in a number of steps in which the trophoblast undergoes a series of interactions with first the LE and then (in species in which the trophoblast breaches the epithelium) the underlying basement membrane and stromal connective tissue.
Carbohydrates and implantation
Although several types of adhesion molecules, notably integrins and fibronectin, are probably involved in firm attachment of the blastocyst, there is now considerable evidence to implicate carbohydrates in the earliest events of implantation (for review see Cross et al., 1994) . The carbohydrate moities of glycoconjugates may extend many microns into the extracellular space beyond the projection of proteins. Therefore, the embryo will first come into contact with the oligosaccharide chains of the apical glycocalyx as the blastocyst is brought into apposition with the LE (Shiotani et al., 1993) . Our results show that the H-type-1 antigen (see Table I ) on the uterus may interact with components of the trophectoderm cell surface to mediate embryo attachment. This structure is carried on a single major glycoprotein of molecular weight 110-120 kDa and a major neutral glycolipid (A.Cook, P.Paulsson and S.Kimber, unpublished results). Attachment of mouse blastocysts to uterine luminal epithelia cells in vitro is greatly depressed in the presence of a pentasaccharide carrying the H-type-1 structure, and the same effect is observed in the presence of a monoclonal antibody which recognizes this structure Kimber, 1994) . H-type-1 antigen is present on all LE cells of non pregnant animals and up to day 4 of pregnancy . On day 5, it is restricted to patches of cells, and by day 6, its presence is negligible. Expression of this carbohydrate antigen is regulated by ovarian steroids in the luminal epithelium, though to a 910 lesser extent, if at all, in the glandular epithelium Kimber, 1994) . A major means of controlling expression of the H-type-1 antigen on the uterine luminal epithelium is via the activity of α1-2 fucosyltransferase (α1-2FT). α1-2FT activity is strongly stimulated by oestrogen and repressed by progesterone in ovariectomized mice (White and Kimber, 1994) and this control operates at the transcriptional level (Kimber and Sidhu, 1997 ; S.Sidhu and S.Kimber, unpublished results). H-type-1 antigen is not expressed on the embryo but, using fluorescently labelled neoglycoproteins, we showed that binding sites for the Htype-1 antigen appear on the fully expanded blastocyst whether directly flushed from uteri or cultured from the two cell stage ( Figure 1A,B) . Appearance of binding sites correlates with hatching of the embryo Yamagata and Yamazaki, 1991; Kimber, 1994) . This indicates the presence of receptor(s) for H-type-1 antigen on trophoblast.
We have recently found that neoglycoproteins carrying the backbone sugar lacto-neo-tetraose (LNT) (see Table I ) also bind murine blastocyst trophectoderm. The LNT-human serum albumin (LNT-HSA) conjugates used in this study carried 50% more sugar groups per HSA molecule than those used in an earlier study which did not produce binding . This apparent discrepancy may be explained by the importance of multivalency and patching of carbohydrate ligands, as has been reported for selectin ligands (Varki, 1994) . In contrast to binding sites for H-type-1, those for LNT appear before hatching of the murine blastocyst. Unhatched human blastocysts also have binding sites for LNT, and not for H-type-1, but hatched human blastocysts have not been tested.
The di-fucosylated histoblood group antigen Le y (Fucα1-2Galβ1-4[Fucα1-3]GlcNAcβ1) (Table I) is present on the late blastocyst (Fenderson et al., 1986) , although in the reproductive tract it is acquired earlier by morulae (Fenderson et al., 1986; Kimber, 1990) . Le y and related mono-and di-fucosylated lactosamine and neo-lactosamine histo-blood group antigens are also expressed by the murine luminal and glandular endometrial epithelium. Some of these appear to be regulated by ovarian steroids (Babiarz and Hathaway, 1988, see below; Kimber et al., 1988; Kimber and Lindenberg, 1990; Kimber, 1994) . Similar structures have been found on human endometrial epithelium, though some were only weakly detected, probably because they are sialylated (Aplin, 1991; Kimber, 1994) . A number of these structures show variation during the menstrual cycle (Aplin, 1991; Ravn et al., 1992 Ravn et al., , 1993 and are up-regulated in uterine malignancy (Inoue et al., 1987; Shiozawa et al., 1991; Tsukazaki et al., 1991; Ravn et al., 1994; Kubushiro et al., 1995) .
Recently, it was reported that injection of anti Le y monoclonal antibody (MAb) into the murine uterus on day 4 of pregnancy (just before the normal time of implantation) blocked implantation of blastocysts during a narrow period, i.e. at 87-93 h post-coitum (Zhu et al., 1995) . The injected antibody became bound to the apical luminal epithelial surface 6-18h after injection but there were no signs of histopathological changes. However, injection of even microlitre quantities of saline or culture medium into the uterus is liable to reduce the percentage of embryos which implant (S.Kimber and S.Lindenberg; C.Spanswick and S.Kimber, unpublished data; C.Finn personal communication). A similar non-specific effect was observed by Zhu et al., but earlier, only around 80h postcoitum and just prior to luminal closure. The severe reduction in implanted embryos at around 80 h was attributed to flushing via the cervix. When tested in a liposome-adhesion assay, Le y glycolipid bound H-type-1 and -2 chain glycolipids adsorbed onto plastic but not Le y , Le x or paragloboside. Our results, together with those of Zhu et al. (1995) , suggest that one receptor for H-type-1 on the apical LE is possibly Le y on the blastocyst. Previous evidence for a direct carbohydratecarbohydrate interaction came from the adhesion stabilization mediated by Le x at compaction. This evidence was based on glycolipid adhesion to Le x adsorbed on plastic (Eggens et al., 1989; Fenderson, 1993) . However, Zhu et al. (1995) failed to perturb implantation by injection of an antibody reported to interact with H-type-1. It is possible that this antibody did not block all sites on the LE. Alternatively, the antibody used by this group may recognize H-type-1 in a different molecular context to the antibody used in our study.
HSPG has also been implicated in mediating initial attachment of the blastocyst (reviewed by Carson et al., 1994) . This glycosaminoglycan (GAG) consists of long chains of O-and N-sulphated glucuronic and uronic acid residues forming polysaccharides covalently attached to a core protein. It is present on the surface of cleavage stage embryos from the 2-cell stage (Dziadek and Timpl, 1985) . More recently, the basement membrane form of HSPG, perlecan, has been detected surrounding the blastocyst at its interface with the luminal epithelium after hatching. Expression correlates with 911 acquisition of attachment competence . Specific heparin/heparan sulphate binding sites have been detected on the surface of murine endometrial epithelial cells isolated from cycling non-pregnant mice (Wilson et al., 1990) . About 9-14% of the estimated 1.3ϫ10 6 high affinity sites found on polarized epithelial cells were on the apical surface. Interaction of mouse blastocysts with laminin, fibronectin and platelet factor IV (all of which bind HSPG/heparin) is inhibited by heparin and heparinase in vitro (Farach et al., 1987) . HSPG binding proteins isolated from uterine epithelial cells also form good attachment substrates for mouse embryos, but do not support outgrowth . Rohde and Carson (1993) used a human choriocarcinomaderived trophoblast cell line, JAR, and a human adenocarcinoma line, RL95, to investigate trophoblast interaction with endometrial epithelium in vitro. By examining the effect of GAGs on attachment of labelled JAR cells to RL95 monolayers, they showed that this occurred by an HSPG/heparin dependent mechanism (Rohde and Carson, 1993) . Enzymatic removal of HSPG from the cell surface, or administration of HSPG in solution, or related GAGs, all inhibited cell-cell adhesion. O-sulphation was found to be important to the inhibitory effect. A series of cell surface heparin/heparan sulphate binding proteins was identified from the cell surface of RL-95 cells by a combination of photoaffinity labelling, radioiodination and heparin-agarose chromatography (Raboudi et al., 1992) . Partial amino acid sequence was obtained from three peptides isolated by heparin-agarose chromatography. Recently one of these proteins has been cloned and given the name heparin/ heparan sulphate proteoglycan interacting protein (HIP) (Liu et al., 1996b) . HIP is a 17 754 kDa protein lacking a membrane spanning domain. HIP was shown to be expressed strongly by the endometrial epithelium throughout the menstrual cycle but, at post-ovulatory day 13, it was also found on stromal cells (Rohde et al., 1996) . It appears to be non-covalently associated with the external surface of the membrane in RL-95 cells and so could function as a binding molecule for HSPG on the trophoblast cell surface. However, there are other candidates for this function. N-CAM is expressed in preimplantation trophectoderm (see above). This molecule can also interact with HSPG and so might bind it to the trophoblast surface.
Another effective luminal epithelial ligand for trophectoderm HSPG is heparin binding epidermal growth factor-like growth factor (HB-EGF). This EGF family peptide can bind to HSPG and to the receptor (EGF-R), both of which are expressed by the hatching blastocyst (Rappolee et al., 1988; Paria and Dey, 1990; Dardik et al., 1992; Carson et al., 1993) . HB-EGF is expressed by the murine endometrial epithelium and stroma. Expression appears to be controlled both by ovarian steroids and by the blastocyst: oestrogen induces HB-EGF in the epithelium while progesterone, or progesterone with oestrogen, induces it in the stroma Zhang et al., 1994) . During pregnancy, HB-EGF mRNA is absent in the luminal epithelium on day 2 and 3. It reappears 6-7 h before the expected time of attachment when it is specifically induced adjacent to the blastocyst in the implantation chamber . The transmembrane HB-EGF precursor protein was also detected on the apical surface of luminal epithelial cells using a specific antibody (Raab et al., 1996) . The nature of the signals from the embryo which induce local expression at the implantation site is unknown. HB-EGF was shown to increase the number of murine blastocysts, to augment the area of trophoblast outgrowth in vitro, and to promote zona hatching. Whether this influence occurs via binding to HSPG, to EGF-R or to both (i.e. HSPG facilitated binding of HB-EGF to EGF-R, Higashiyama et al., 1993) is not yet clear. HB-EGF treatment leads to phosphorylation of the EGF-R suggesting that this is at least one route by which trophectoderm/trophoblast cell behaviour is modified. It is possible that HB-EGF has a dual function, interacting with blastocyst surface HSPG/EGF-R as a cell adhesion molecule while simultaneously influencing other cell functions via signals transduced through the EGF-R. This is supported by the finding that murine blastocysts bind to cells which express the transmembrane form of HB-EGF in far greater numbers than to those which express the mature secreted form (Raab et al., 1996) . Binding is, at least partially, heparinase sensitive.
Immediately after implantation (day 6.5 in mouse) N-CAM and poly α2-8 sialic acid can no longer be detected on the murine embryo or extraembryonic tissues. Their disappearance correlates with trophoblast outgrowth in vitro . A higher proportion of polylactosamine chains appear to be capped with sialic acid residues in early cleaving embryos than in later peri-implantation stages, while on the trophectoderm of the expanded and implanting blastocyst, terminal sialic acid is much reduced (Pennington et al., 1985) .
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This suggests a general reduction in sialylated structures on trophoblast at the time of implantation.
An association between invasion and a specific cell surface glycosylation profile has been suggested for metastasizing tumours and may also be important for trophoblast. For example, β1-6 branched asparagine-linked oligosaccharides which appear to be required for tumour cell invasion and metastasis (Dennis et al., 1989) , are also expressed on invasive first trimester human trophoblast. Moreover, if branching was blocked during formation of complex N-linked saccharides, basement membrane invasion of trophoblastic cells was inhibited (Yagel et al., 1990) . Similarly, increased α-Gal may correlate with metastasis (Yogeeswaran, 1983) while the α-Gal-containing B blood group antigen is a useful marker for trophectoderm and invading trophoblast in the mouse (Azuma et al., 1991; Kimber et al., 1993) . However, in the mouse, α-Gal residues are expressed at the late morula stage at least 36 h before invasion begins. Indeed, our data suggest that it is one of the earliest markers of trophectoderm differentiation. The lectin IB4 from Griffonia simplicifolia, which recognizes the B-blood group antigen, stains human villous trophoblast up to week 10 of gestation irrespective of blood group status (Foidart et al., 1990) . Staining is absent by week 13-14. Invasive interstitial and vascular trophoblast also stain during the first trimester and, with parietal trophoblast, still stain for α-Gal at term. Based on the finding of strong staining on proliferating hydatiform mole cells and on a choriocarcinoma cell line, Foidart et al. (1990) suggested that α-Gal residues may be connected with trophoblast invasion.
In women, other endometrial epithelial carbohydrate structures such as keratan sulphate have been associated with implantation success. These are MUC-1 associated (Graham et al., 1990; Hoadley et al., 1990; Aplin et al., 1994; Hey et al., 1995) , as are some histoblood group antigens (e.g. Le x ) (Aplin and Hey, 1995) . How these influence the human embryo is still an open question and outside the scope of this review (see Aplin et al., 1994) .
Carbohydrate binding molecules in implantation
There is preliminary evidence for expression of P-selectin on the human preimplantation embryo (Campbell et al., 1995a) . Weak binding has also been detected with antibodies to human L-selectin on murine blastocysts but not at earlier stages (D.Bloor and S.Kimber, unpublished results). Homozygous null mutant mice for all three selectins have been produced but these appear to undergo normal embryonic development and implantation (Mayadas et al., 1993; Arbones et al., 1994; Labow et al., 1994) . Thus the significance of the preimplantation expression of selectin is unclear.
Expression of several members of the galectin family is initiated in the preimplantation embryo. Both galectin 1 and galectin 3 appear in trophectoderm cells at the time of hatching (Weitlauf and Knisley, 1992; Poirier et al., 1992; Poirier and Robertson, 1993) . In contrast, cells of the inner cell mass are devoid of galectins 1 and 3 ( Figure 1C,D) . Although the subcellular localization of the two galectins is generally different, they are both present on the surface of the implanting blastocyst. This observation led us to propose the hypothesis that galectins 1 and 3 might act as receptors for the H-type-1 antigen present on the LE. This idea is supported by the affinity of both galectin 1 and galectin 3 for the H-type-1 epitope (Sparrow et al., 1987) . Alternatively, since galectins are major non-integrin laminin binding proteins (Zhou and Cummings, 1990; Woo et al., 1990; Cooper et al., 1991) , it is conceivable that they contribute to the complex interactions taking place with laminin at the time of implantation. For example, it has been shown that galectin 1 can selectively modulate the interactions between α 7 β 1 integrin and laminin during skeletal muscle differentiation (Gu et al., 1994) . However, the generation of mice in which either the galectin 1 or galectin 3 gene is deleted has shown that both of these mutations are viable and the animals are fertile (Poirier and Robertson, 1993; Colnot et al., 1997) . Moreover, the coexpression of galectins 1 and 3 cannot account alone for the lack of phenotype since double mutants missing both galectin 1 and galectin 3 also implant successfully (Colnot et al., 1997) . However, any subtle consequence of these mutations on the rate of implantation would not have been noticed in our limited studies. We have now undertaken a systematic search for further galectins in the implanting blastocyst. Interestingly, we have found that blastocysts are also stained with an antibody raised against galectin 5 (Gitt et al., 1995) and that this new galectin is present both in the trophectoderm and in the inner cell mass. In addition, it appears to be located in the nucleus and also on the membrane of trophectoderm cells ( Figure  1E , M.A.Ripoche and F.Poirier, unpublished results). Taken together, these results indicate that several members of this family of lectins are recruited at the implantation stage, in sharp contrast to their distinct patterns of expression at later developmental stages (Colnot et al., 1997) . It is possible that these molecules have redundant functions in the trophectoderm at implantation, thus safeguarding this critically important process.
Glycosylation in the early mammalian embryo
Are particular categories of carbohydrates essential to early development? This question has been addressed of complex and hybrid oligosaccharide chains N-linked to protein. Mouse mutants have been produced which are homozygous null for the glycosyltransferase necessary for conversion of high mannose precursors to complex and hybrid chains (N-acetylglucosaminyltransferase 1; Mgat-1). These develop normally to early postimplantation stages but by~8.5-9.5 days of development, their growth is retarded (Ioffe and Stanley, 1994; Metzler et al., 1994; Campbell et al., 1995c) . Mutant embryos do not survive beyond 10.5-11.5 days which corresponds to the time of up-regulation of Mgat-1 mRNA in the wild type (Campbell et al., 1995a) . Thus, it may be concluded that complex N-linked carbohydrate chain synthesis per se does not appear to be essential for preimplantation development, implantation, or gastrulation. However, when postimplantation embryos were stained with a lectin (E-PHA) that recognizes a trisaccharide specific to N-linked complex carbohydrates, the extraembryonic endoderm, though not the embryonic portions, of Mgat-1 mutants stained for the complex N-glycan structure, as in the wild type. In addition, at the blastocyst stage, wild 913 type and Mgat-1 mutant embryos were indistinguishable by the criteria of E-PHA staining (Campbell et al., 1995c) . Therefore, mutant embryos, though lacking the critical Mgat-1 enzyme, clearly obtain N-linked chains via another route and we cannot conclude from these experiments that the early embryo is able to develop in the absence of complex chains. The maternal system has various possible routes by which to provide the early embryo with such molecules: Mgat-1 mRNA deposited in the oocyte, oocyte-derived Mgat-1 enzyme or Nlinked glycoproteins, or by uptake of maternal enzyme or glycoproteins from the reproductive tract. Though the latter may seem unlikely, blastocysts were most strongly stained with E-PHA on the zona pellucida. Furthermore, a number of cell surface glycoproteins or lipids have been reported to be derived by embryos from the reproductive tract (Gaunt, 1985; Fenderson et al., 1986; Kapur and Johnson, 1988; reviewed in Kimber, 1990) . However, many terminal carbohydrate structures that have been found to be relatively stage-or tissuerestricted during early embryonic development can be carried on glycolipids as well as O-or N-linked to protein (see also Feizi, 1985; Stanley and Ioffe, 1995) . Overexpression mutants have also been constructed in a few cases (for review, see Stanley and Ioffe, 1995) . For example, In transgenic mice carrying a construct for a sialic acid specific 9-O-acetylesterase, 9-O-acetyl-GD3 was absent in normally expressing tissues. When this enzyme was expressed under a metallothionein promoter (although not an alternative promoter) transient expression at the 2-cell stage led to developmental arrest suggesting an absolute requirement for 9-O-acetylation of sialic acids for cleavage (Varki et al., 1991) . Overexpression of α1-3 Gal transferase did not effect embryos prenatally (Ikematsu et al., 1993) , while overexpression of β1-3Gal transferase in spermatozoa led to reduced sperm-zona binding in vitro but normal fertilization in vivo (Youakim et al., 1994) .
One of the five murine α1-3 fucosyltransferase genes which could construct the Le x epitope in the embryo has also been deleted, but homozygous null embryos apparently undergo normal preimplantation development and implantation (Maly et al., 1996) . A normal Mendelian ratio of progeni are born, although leukocyte rolling is affected after inflammatory challenge in the adults. As further null mutants for enzymes affecting glycosylation are produced, and precisely targeted to specific embryonic stages or tissues, the absolute requirements for different types of glycosylation and glycosylated structures during development will become clearer.
Concluding remarks and perspectives
Recent years have seen great progress in cataloguing the changes in carbohydrate that occur at cell surfaces during early embryogenesis. However, without functional tests of their importance, it is difficult to determine whether these changes merely reflect the different states of cells or whether they have true functional significance in cell-cell communication. Future progress may depend on developing robust in-vitro assays for the cell interactions which are believed to be mediated by carbohydrates. This, plus the continued application of genetic techniques for altering carbohydrate synthesis or surface expression, should provide a better understanding of this class of molecules.
So far, the existing mutants do not reveal absolute requirements for particular glycosylation steps, except perhaps 9-O-acetylation of sialic acid, or for a particular lectin during early embryogenesis. In fact, the process of uterine implantation appears to be compatible with a large number of different null mutations in genes coding for cell adhesion molecules and their ligands. For example, it is remarkable that homozygous null mutants for α 5 integrin (Yang et al., 1993) or fibronectin (George et al., 1993) die only during midgestation or slightly later. Lethality at pre-or peri-implantation stages has been observed for a very limited number of genes, such as ZP3 (Liu et al., 1996a; Rankin et al., 1996) , E-cadherin (Larue et al., 1994) , β 1 integrin (Stephens et al., 1995) . This might reflect a high degree of redundancy: in the case of glycosyl transferases, for instance, at least five enzymes capable of catalysing the Fuc α1-3 GlcNAc linkage have now been cloned. Although these have slightly different substrate specificities and show restriction in cell type expression, it is possible that, in the absence of one member of the family, transcription of another is induced. An example of this is seen in null mutant mice for Myo D, a transcription factor involved in muscle cell development, in which transcription of the Myf5 gene, also coding for a transcription factor, increases threefold, apparently to compensate (Rudnicki et al., 1992) . Alternatively, it is possible that key molecules remain to be inactivated or have not even been identified.
However, mouse mutants have brought direct proof of the involvement of carbohydrate in some fundamental processes involved during embryogenesis (Ioffe and Stanley, 1994) . Detailed analysis of the galectin 1 mutants has now revealed that a subset of primary olfactory neurons fail to project to their correct target sites in the caudal olfactory bulb, indicating that this particular lectin is involved in the growth or guidance of these axons (Puche et al., 1996) . This is the first demonstration of the long suspected role of carbohydrates in neuronal pathfinding in the mammalian nervous system (Dodd and Jessell, 1986) . Based on this type of information, lectins are now being sought in the Drosophila nervous system (Tiemeyer and Goodman, 1996) .
We have mainly envisaged carbohydrate-carbohydrate and lectin-carbohydrate interactions to be intermediates of cell adhesion, but anti-adhesive properties should also be considered, particularly for galectins (Cooper et al., 1991) . Lectincarbohydrate interactions are clearly important in cell recognition (Sharon and Lis, 1989; Hakomori, 1992; Hughes, 1992) , and could well result in transduction of various signals depending on the cell type and the developmental stage. For example, galectin 1 has been ascribed the role of a growth factor in vascular cells (Sanford and Harris-Hooker, 1990 ) and as a trigger of apoptosis in T cells (Perillo et al., 1995) . There is abundant evidence for the role of extracellular matrix in transmitting information transduced via cell surface receptors (Adams and Watt, 1993) . We envisage that carbohydrates and lectins could be intermediates in signalling and, indeed, it is known that carbohydrates are able to bind growth factors. The interaction of fibroblast growth factor (FGF) with HSPG as a prerequisite in the binding of FGF to its protein receptor is now well established (Gallagher, 1994; Schlessinger et al., 1995) . Similarly, the presentation of HB-EGF to the EGF receptor operates via binding to a proteoglycan (Higashiyama et al., 1993) . Drosophila wingless has recently been proposed to act as a growth factor whose action is mediated through binding to extracellular proteoglycans (Reichsman et al., 1996) .
Finally, glycosylated molecules are not exclusively located at the cell surface and in the extracellular matrix but can also be found intracellularly in the cytoplasm as well as in the nucleus (Hart et al., 1988) . Glycosylation of the Sp1 transcription factor (Jackson and Tjian, 1988) and the c-myc protooncogene (Chou et al., 1995) for example, is thought to modulate the activity of these molecules. Lectins, notably galectins, are also found in the nucleus (Hubert et al., 1989; Wang et al., 1991) and evidence suggesting a role for galectin
